Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cancer Research UK
American Society of Clinical Oncology
National Cancer Institute (NCI)
Princess Maxima Center for Pediatric Oncology
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute